


Searching News Database: capsid
HSMN NewsFeed - 1 May 2025
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
HSMN NewsFeed - 10 Sep 2024
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
HSMN NewsFeed - 8 Jun 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 18 May 2021
Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
HSMN NewsFeed - 13 Jun 2018
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
HSMN NewsFeed - 26 Sep 2014
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
HSMN NewsFeed - 13 Feb 2009
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
HSMN NewsFeed - 9 Feb 2009
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
HSMN NewsFeed - 27 Aug 2007
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
HSMN NewsFeed - 5 Jul 2007
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
HSMN NewsFeed - 1 May 2007
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
HSMN NewsFeed - 28 Sep 2006
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
Additional items found! 9
Members Archive contains
9 additional stories matching:
capsid
(Password required)
capsid
(Password required)
